Although not determined in this study, it is tempting to speculate that Dab2 promoter hypermethylation is associated with a specific subtype of breast cancer, the basal subtype, as these tumours have been shown to specifically exhibit an EMT-like phenotype (Dumont et al, 2008; Sarrio et al, 2008). Here, DAB2 is linked to breast carcinoma.